Barratt, J., Rovin, B., Diva, U., Mercer, A., & Komers, R. (2019). Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial). Kidney Int Rep.
シカゴスタイル引用形Barratt, Jonathan, Brad Rovin, Ulysses Diva, Alex Mercer, , Radko Komers. "Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)." Kidney Int Rep 2019.
MLA引用形式Barratt, Jonathan, et al. "Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)." Kidney Int Rep 2019.
警告: この引用は必ずしも正確ではありません.